Jim Hoffman։ Targeting NETosis to Improve Perfusion and Reduce Thrombosis in AMI
Jim Hoffman, Former Technical Advisor at Cygnus Technologies, LLC, posted on LinkedIn about a recent article by Robert Chilton et al, published in National Library of Medicine:
”’Overall, understanding the role of NETosis in AMI provides valuable insights into the disease’s pathophysiology and highlights potential therapeutic targets to mitigate the inflammatory and thrombotic components of heart attacks’ Chilton et al 2024
How about helping patients clear NETs/extracellular chromatin from their blood so they can potentially phagocytically remove and catabolize this unwanted chromatin better from their tissues?
This could greatly improve circulatory perfusion, reduce unwanted thrombi formation, and reduce the chances of exacerbated cell death leading to organ dysfunction(s) and failure(s). Poor dietary-related gut dysbiosis, poor insulin and glucose homeostasis are likely directly related and worsened by NETosis dysregulation.”
Title: The web of intrigue: unraveling the role of NETosis within the gut-microbiome-immune-heart axis in acute myocardial infarction and heart failure
Authors: Tai Yasuda, Kate Deans, Aditi Shankar, Robert Chilton
Read the Full Article on National Library of Medicine.
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 17, 2026, 04:07Weihao Li: Global HEPATIC Registry Findings on Post-Transplant Arterial Thrombosis
-
Oct 17, 2026, 03:56Ghaith Abu-Zeinah: ASH Publishes 2026 Guidelines for Myelofibrosis Management in Blood Advances
-
Oct 17, 2026, 03:48Tristan Siokos: Why Vascular Occlusion Is More Than Just Clots – Breakdown of the 8 Pathways
-
Oct 17, 2026, 02:36Archil Jaliashvili: Oxygen Transport in Capillaries
-
Oct 17, 2026, 02:35Carly Newton: Understanding Access to Red Blood Cell Exchange for People Living With SCD
-
Oct 17, 2026, 02:34Raising Awareness of Blood Clots During and After Pregnancy – Thrombosis UK
-
Oct 17, 2026, 02:33Alaa Salamat: Our Research Accepted for Publication at ASH 2026
-
Oct 17, 2026, 02:32Mohammed Al Sharif: Discussing Factor XIII Testing and Its Clinical Significance
-
Oct 17, 2026, 02:31Joanna Popiolek-Kalisz: Talking about Novel Pharmacotherapy for Hypertension at CV Prevention and Intervention